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Docosahexaenoic acid (DHA) is the most abundant omega-3 fatty acid in the mammalian brain (1) , accounting for 8-14% of fatty acids perinatally in primates (2) and humans (3, 4) . In humans, DHA accumulates at an accelerating rate from mid gestation reaching an inflection point during the first months after birth (5) and continuing well past the plateau of brain weight to reach a plateau around18 years of age and remain stable to the end of life (6) .
DHA can be synthesized de novo by term and preterm human infants from precursor omega-3 fatty acids, α-linolenic acid (ALA) or eicosapentaenoic acid (EPA) (7-9) but the process is generally considered to be inefficient, also challenged by current dietary intakes of omega-6 linoleic acid at relatively high levels (10, 11). Direct measurement of percent incorporation of DHA into the primate brain from precursor ALA indicate that it is 7-fold less efficient than for preformed DHA. This finding is in contrast to that for arachidonic acid (ARA), present in the brain at similar/comparable levels but not strongly affected by dietary preformed ARA (12). Numerous human studies have shown efficacy of dietary preformed DHA to support brain and visual development (13), and follow-up studies suggest that preformed DHA intake in infancy provides long term benefits on specific tests of higher cognitive function, although it is widely agreed that no effects can be seen using the Bayley scales, a standard test for normalcy (14) .
While all preformed DHA is structurally identical, in human foods and food supplements DHA is normally esterified to one of three lipid classes as molecular Positional specificity may be metabolically relevant for subsequent metabolism as fatty acids are incorporated into membranes, oxidized, or excreted on the skin.
Previously we showed by 13 C labeling that ARA-PL, specifically as phosphatidylcholine (ARA-PC), when added to artificial formula is about twice as efficacious as a substrate for supplying ARA to the brain as ARA-TAG in neonatal baboons (21). We report here a similar study in neonatal piglets using 13 C-DHA, specifically investigating efficacy for supplying the gray matter of the cerebral cortex with DHA. 
Animals and diet
The overall study and all procedures involving live piglets were approved by the The fatty acid profile of the milk replacer (piglet milk formula) is presented in Table 1 .
DHA is present in low levels in form of TAG (0.02 %, w/w) and PL (0.11 %, w/w). TAG, PL, and related DHA measurements are presented in Table 2 , when appropriate tabulated for a 500 mL feeding used with the dose. As with human milk and human infant formulas, total energy from fat was about 47% and mostly in the form of TAG (94%). Despite the low absolute DHA concentration in TAG, the predominant mass of TAG over PL provided 73% of total DHA compared to 27% from PL, in line with human milk and other mammalian milks.
Fresh formula was provided every 6 hours for the first week and 8 hours thereafter in individual troughs as in our previous studies (23, 24). All piglets had free access to fresh water. Formula consumption for each group was recorded daily for the first week to insure the piglets thrived, and monitored every third day thereafter. Piglet body weight was recorded every other day in the first week and every third day thereafter.
Home cage enrichment, included bedding, contact with other piglets, positive human contact and rubber toys.
Dose and sampling
On day 16 of life, 16 robust piglets out of a total set of 20 piglets were assigned to two dosing groups, PC and TAG, balanced with respect to gender, weight, and age but otherwise distributed randomly. Group PC was orally dosed with PC-13 C-DHA as described below. Group TAG was dosed with TAG-13 C-DHA. The four smallest piglets were used as natural abundance isotopic controls and did not receive a dose but were otherwise treated identically to the other animals.
Doses were prepared by dissolving CHCl 3 solutions of PC-13 C-DHA or TAG- The resulting labeled formula was split gravimetrically into 1 to 2 mL aliquots and administered orally to piglets via syringe. Labeled formula was withdrawn by syringe from the vials which were subsequently washed several times with unlabeled formula which was then also administered to the piglets at the beginning of a normal feeding time. Piglets were therefore hungry but could be considered as fasted insofar as their normal meal interval was concerned. Care was taken to insure all of the labeled formula and the washes, consisting of a total of up to 10 mL, were swallowed by the piglets. Piglets were then provided with their normal meal of 500 mL milk replacer which they routinely consume completely. Doses to piglets corresponded to about 20 mg 13 C-DHA delivered in PC and 86 mg of 13 C-DHA delivered in TAG, and the difference was only due to the amount of each labeled tracer that was available.
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Six days after the receiving the labeled DHA dose and in total 20 days of formula and 22-24 days of life, all piglets were euthanized by exsanguination under anesthesia on a single day. Blood for fatty acid analysis was collected in tubes with EDTA and spun to prepare red blood cells. The surface few mm of the gray matter on the cerebral cortex superior surface was rapidly collected at necropsy. A piece approximately 5 × 10 × 3 mm was immediately used for preparation of synaptosomes, and the remaining gray matter was snap frozen in liquid nitrogen for fatty acid analysis. Retina, heart, liver, biceps and femoris muscle were also harvested, and all tissues were snap frozen and stored at -80°C until prepared for analysis.
Synaptosomes were prepared using Syn-PER Synaptic Protein Extraction Reagent (Thermo Scientific, Waltham, MA, US) according to manufacturer's instructions.
Briefly, 1 ml of Syn-PER Reagent was added to ~100 mg brain tissue sample.
Samples were homogenized and the homogenate centrifuged at 1,200 g for 10 mins.
The supernatant was collected and further centrifuged at 15,000g for 20 mins.
Synaptosomes were recovered from the pellet and lipids were immediately extracted as described below.
Lipid extraction and analysis
Total lipids were extracted from samples of brain gray matter, the synaptosome pellet, liver, heart, and retina. Samples were simultaneously digested and fatty acid methyl esters (FAME) prepared using a one step method as described in detail previously Tracer analysis for 13 C-DHA is performed on FAME mixtures using similar GC column conditions as for the quantitative analysis, as has been described in detail previously (27) . Instrumentation for tracer analysis is an Agilent 6890 gas chromatograph coupled to a combustion furnace interface, and to a Thermo Scientific 253 isotope ratio mass spectrometer (IRMS). FAME eluting from the GC are combusted to CO 2 , dried, and admitted to the IRMS. Data processing is as described previously (21).
Isotope ratios in the conventional high precision notation, δ 13 C, defined previously (27), is converted to fraction of 13 C. For each fatty acid, the mean isotope ratio of the control group was subtracted from the isotope ratio of the means for the enriched groups to by guest, on October 22, 2017
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yield an atom fraction enrichment, which was subsequently converted to %Dose, which reflects the appearance of tracer in the specific pool. The primary outcome is a relative comparison of the %Dose appearing in the brain gray matter for TAG and PL, respectively. Total %Dose found in liver and retina was calculated directly from their respective weights. The total labeled DHA in cerebral gray matter and RBC was estimated based on brain weight, and using the relative amount of gray matter in the brain as 60%, estimated from human imaging data (28). For RBC, the blood volume was estimated as 8.5% of body weight (29) and hematocrit was about 35%. For gray matter synaptosomes, we did not attempt to estimate the total amount and normalized the %Dose to the highest value found. In all cases, estimated masses apply to both experimental groups and cancel in the primary and secondary outcome calculations, and thus do not affect the final results. Detailed calculations have been previously presented (21).
Statistics.
Primary Outcome, relative DHA %Doses from PC and TAG. The primary outcome is the relative %Dose of 13 C-DHA found in the gray matter of the cerebral cortex in the PC-13 C-DHA vs the TAG-13 C-DHA dosed groups. The %Dose in the two dosing groups were tested for equivalence by one way analysis of variance with p<0.05 considered significant.
Secondary outcomes. Total unlabeled fatty acids in the various pools were compared in a pairwise manner in the two dosing groups and were not significantly different, and were therefore pooled. Since these two groups were fed the same formulas and treated identically except for a few mg doses, no differences were expected based on treatment.
Relative 13 C-DHA %Doses for synaptosomes, retina, liver, and RBC were compared for similarity to the primary outcome. Relative meal wise amounts of total DHA delivered in TAG and PL were calculated from the determination of relative amounts of unlabeled DHA in formula in a 500 ml meal.

Results
Piglets in both dosing groups grew at comparable rates and attained non-significantly different final weights of 9.4±0.3 kg and 9.1±0.4 kg for the PC and TAG dosed groups, respectively. The isotopic control groups were purposely chosen as the smallest animals but grew in parallel to the other groups, starting at about 6% lower body weight and finishing at about 12% lower weight. These animals were expected to yield accurate estimates of baseline isotope ratios, which were applied identically to both experimental groups.
The fatty acid profile of neural tissue is presented in Table 3 . Retina was richest in DHA (22:6) at 12%, followed by gray matter (8.3%) and white matter (5.2%).
Docosapentaenoic acid (22:5n-6), the DHA analogue among omega-6 fatty acids, mean value was 9.7% in gray matter, and thus slightly greater than DHA. Domestic piglets have long been considered to require small amounts of linoleic acid and that n-3 incidental to practical diets is sufficient to support rapid growth (30) . These levels are apparently insufficient to enable DHA levels similar to wild animals (1) though they are apparently developing normally.
Results for the primary outcome in gray matter and gray matter synaptosomes are presented in Figure 1 . 13 C label was detected only for DHA and 22:5n-3 (DPAn-3)
among all fatty acids. The %Dose detected in cerebral cortex gray matter in the Results in gray matter synaptosomes, also shown in Figure 1 , were consistent with the relative values. The ratio of relative accretion of labeled DHA in the synaptosomes was 1.7-fold greater for PC than for TAG.
The retroconversion product DPAn-3 was labeled below 0.05%Dose for the PC dose group and less than half of that for the TAG dose group. The relative efficacy of PC over TAG for the retroconversion of DHA to DPAn-3 was about 2.8. For gray matter synaptosomes, the superiority of PC over TAG was the same with a relative efficacy of 2.8. Gray matter and synaptosome 13 C-DHA was approximately 10-fold greater than 13 C-DPA. Consistent with the present data, albumin-bound sn-1-lyso-2-DHA-PC is more efficiently incorporated into brain PL in the rat compared to unesterified DHA (33, 34) . In our study, 1-lyso-2-13 C-DHA-PC can be synthesized by a phospholipase A1 action on 13 C-DHA-PC, recently proposed to be mediated by an endothelial lipase (35) , analogous to results suggesting extensive phospholipase A1 activity mediated by hepatic lipase (36) . This pathway would not be available to DHA-TAG, and could at least in part mediate some of our whole body results. A very recent report shows that mice expressing human apoE4 take up less unesterified DHA and have lower brain DHA compared to mice expressing apoE2 or apoE3, suggesting a mechanism involving free DHA as well (37). A DHA-specific lysophosphatidic acid acyl transferase that may mediate specific transfer of unesterified DHA into phospholipids was also recently reported (38).
The majority of dietary DHA was carried as TAG because of its greater proportion of DHA compared to PL in the formula (piglet milk replacer) ( Figure 1C ,D, 2C,D, 3B).
Qualitatively, this is comparable with the composition of human/mammalian milks of other species. However, the amount of DHA in our piglet formula was very low, probably only being a minor component of bovine milk protein as base of the formula.
Variation in human milk DHA is over at least an order of magnitude, from 0.1% to over The retroconversion product DPAn-3, though also almost 3-fold greater in the liver for PC compared to TAG, was a smaller proportion of the liver 13 C-DHA than found in gray matter. In gray matter, 13 C-DHA was about 8-fold greater than 13 C-DPA while in liver the 13 C-DHA was 40-fold greater. If DPAn-3 had been synthesized in the liver and transported to the brain, similar ratios would be expected. These observations suggest that retro-conversion takes place in organs other than the liver and may well be more active in the brain than in liver.
The piglet has long been used as a model for infant nutrition because of its similar about 22% of the EPA and DHA in one krill oil product is in the form of free fatty acids, which is at least several fold greater than normally found in foods or supplements (48).
In the first day post-dose, the timing and peak of blood levels is generally greater when ingested as free fatty acids, and similar to that of TAG (49, 50) and/or as PL compared to ethyl esters. However, these short term kinetics may not correspond to long term differences in DHA status as measured in human blood pools (48). Notably, however, blood FA status reflects fatty acids in circulation and does not address the uptake and incorporation of specific FA's into target tissues, which can be measured directly with isotopically labeled precursors in animal models. Greater efficacy of PC compared to TAG carrier for ARA found with 13 C-precursors in previous studies (21, 51) led to speculation that the same would be the case for DHA. Others have considered the relative efficacy of labeled DHA as carried by TAG and PC in the rat (52) . In a previous study with radiolabeled ( 14 C) version of the same lipids we considered here, PC-DHA was twice as efficacious for brain DHA accretion as TAG-DHA at 10 weeks but not earlier. The peak of the rat brain growth spurt is maximal between 1 and 2 weeks (53), and accordingly the rat is long past the developmental time when the brain is growing.
It is possible, however, that rat brain DHA may continue past the time when the brain ceases to increase in weight, similar to humans (6). The brains of our piglets were certainly increasing in weight during the period of our study and indicate that the advantage of PC is found perinatally. The pig is generally considered a good model for human brain development because it is among the few experimental animals with a brain growth spurt similar to humans (53) , and it is a large non-ruminant omnivore. We did not find labeling in 20:5n-3 which would have been expected if 18:3n-3 was elongated with labeled acetate, and no evidence of label in other fatty acids,
suggesting that the acetate pool was not a factor. In humans, 22:6n-3 β-oxidation is low compared to other fatty acids (55) . These considerations all suggest that the label in 22:5n-3 did not proceed via acetate.
The pathway by which this transition occurs is not clear. The last few steps of the widely accepted coupled mitochondrial-peroxisomal pathway of 22:6n-3 synthesis proceed as (20:5→22:5→24:5→24:6)→22:6, where all but the last step occurs on the endoplasmic reticulum, and 24:6 is transported to the peroxisomes for one round of β-oxidation (56), the latter of which is a four step FAD and NAD dependent process.
Retroconversion in the sense of reversal of this pathway would require entry of 22:6n-3 into peroxisomes for an energetically and entropically expensive reversal of β-oxidation to yield 24:6n-3, followed by transport to the ER for a reversal of Gray matter DPA was greater than in reported for other species, and DHA lower (Table 3) . Gray matter DHA in normal neonatal baboons has recently been found to be around 12-14%, while DPA was between 1-2% (2). DPA is well known to rise in neural tissue when omega-3 fatty acids are limited in the diet and with omega-6 being more abundant. It has been used as an index of relative omega-3 deficiency (59). In well nourished normally growing piglets, the relatively high amount of DPA indicates active demand for highly unsaturated fatty acids and presumably a maximally upregulated pathway for their biosynthesis. The sum of DHA and DPA in gray matter was 18%(w/w), similar to that for normal primates of about 16% (w/w). White matter consisting of a large proportion of mostly saturated myelin has 5.2% DHA and 3.7%
DPA, suggesting that the DHA supply more adequately satisfies the demand in white matter. Although retinal DHA concentration is high, the total retina mass is small and the total DHA required is correspondingly small. We previously showed in primates that small neural structures normalize DHA levels at lower dietary concentrations of DHA than the very large cerebral cortex (2); these data are thus consistent.
In summary, stable isotope tracer doses of DHA bound in the sn-2 position of PC was 1.9-fold more efficacious for supply of cerebral cortex gray matter than DHA bound to the sn-2 position of TAG. These data are generally consistent with numerous previous measurements on other LCPUFA and on DHA studied in other species. Together with previous work, the results indicate that PC is a highly efficacious source of both DHA and ARA, the two major LCPUFA of human breast milk (60). Liver retained about 7% of the DHA from the PC dose at 6 days compared to about 3.8% for the TAG dose, corresponding to a relative efficacy of about 1.9; PC-derived DPAn-3 was significantly greater than TAG-derived DPAn-3, with a relative efficacy of 
